Inactivation or loss of PTEN protein expression is found in up to 30% of sporadic CRC [30,31] and is likely to be associated with resistance to anti-EGFR monoclonal antibodies in KRAS-wt patients [32]. The gene discussed is PTEN; the disease is colorectal carcinoma.